Company
A next-generationneurotoxin biotechnology company.
Object Pharma is developing differentiated botulinum neurotoxins designed to unlock new therapeutic possibilities — beginning with Major Depressive Disorder.
Who we are
A specialized biotechnology company advancing botulinum neurotoxin science — an innovative, fully integrated biopharma company dedicated to the development of new therapies for the treatment of mental illness.
Why we exist
To explore innovative therapeutic approaches addressing significant unmet medical needs, with a central commitment to mental and brain health.
Our primary focus
Major Depressive Disorder, through the development of OP01 — NextGen, our lead investigational candidate.
Our broader scientific interests
Exploring the wider therapeutic potential of botulinum neurotoxins — a proven therapeutic class whose biology may extend further.
People
Meet the team behind the science
Founding
Founded on July 13, 2018, Object Pharma was established to develop novel neurotoxins as human therapeutics.
Metabiologics
The addition of Metabiologics brought specialized neurotoxin production expertise and research infrastructure into the Object ecosystem.
OP01
Object Pharma initiated development of OP01, its lead investigational neurotoxin candidate, initially for Major Depressive Disorder.
ObNowa Pharma
The establishment of ObNowa Pharma expanded Object Pharma's ecosystem into European pharmaceutical development and medical aesthetics.
Three organizations.
One connected capability.
Metabiologics
Madison, Wisconsin
Neurotoxin science & specialized capabilities
- Serotypes A–G research materials
- Production know-how
- Scientific infrastructure
- Institutional neurotoxin knowledge
Object Pharma
Aliso Viejo, California & Madison, Wisconsin
Neurotoxin innovation & therapeutic development
- Mental & brain health mission
- OP01 — NextGen — MDD
- Differentiated neurotoxin candidates
- Global opportunities
ObNowa Pharma
Warsaw, Poland
European development & commercialization
- European clinical development
- Regulatory strategy & partnering
- Medical aesthetics — incl. licensed hair & eyebrow programs
- Commercialization
The companies of the Object ecosystem operate distinct programs; not every program is shared between the three companies. ObNowa program details are described at a high level only.
Our Purpose
Help people.Minimize suffering.Follow the science.
Science is the mechanism. Patients are the reason.




